BBNX
Beta Bionics, Inc. · Healthcare · Medical - Devices
Señales de momentum (gestores comparables):
amplitud de titulares +16.7% ·
flujo de acciones -4.7% ·
nuevas posiciones netas +14.3%
— fórmula
Fragmentación de la titularidad — más titulares, participación agregada menor
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 55 | -3 | 20.53M | $322.26M | +5 | −9 |
| Q1 2026 | 61 | -7 | 19.12M | $192.20M | +3 | −11 |
| Q4 2025 | 69 | +1 | 20.16M | $614.71M | +4 | −2 |
| Q3 2025 | 15 | -2 | 17.35M | $344.76M | — | −2 |
| Q2 2025 | 14 | +2 | 8.16M | $118.68M | +3 | −1 |
| Q1 2025 | 9 | +9 | 6.98M | $85.04M | +9 | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 3.90M | 0.0% | $56.68M | 0.0% | Held | 2 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 858.36K | — | $12.50M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (pasivo) | 858.36K | — | $12.50M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 858.36K | — | $12.50M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 858.36K | — | $12.50M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 858.36K | — | $12.50M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | The Vanguard Group ✦ (pasivo) | 706.97K | — | $10.29M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | The Vanguard Group ✦ (pasivo) | 706.97K | — | $10.29M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | The Vanguard Group ✦ (pasivo) | 706.97K | — | $10.29M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Marshall Wace ✦ | 614.97K | -8.7% | $8.95M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Marshall Wace ✦ | 614.97K | -8.7% | $8.95M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Millennium Management ✦ | 542.20K | Nuevo | $7.89M | 0.0% | New | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 539.96K | -42.9% | $7.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 317.94K | -50.0% | $4.63M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 317.94K | -50.0% | $4.63M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Geode Capital Management ✦ (pasivo) | 312.93K | +2.3% | $4.56M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Geode Capital Management ✦ (pasivo) | 312.93K | +2.3% | $4.56M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | State Street Global Advisors ✦ (pasivo) | 230.00K | +117.0% | $3.35M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 55.43K | Nuevo | $807,105 | 0.0% | New | 1 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 55.43K | Nuevo | $807,105 | 0.0% | New | 1 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 55.43K | Nuevo | $807,105 | 0.0% | New | 1 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 55.43K | Nuevo | $807,105 | 0.0% | New | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 55.43K | Nuevo | $807,105 | 0.0% | New | 1 | SEC ↗ |
| 24 | Soros Fund Management ✦ | 25.00K | -3.7% | $364,000 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 25 | Two Sigma Investments ✦ | 21.30K | +2.6% | $310,070 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 26 | Renaissance Technologies ✦ | 16.50K | Nuevo | $240,240 | 0.0% | New | 1 | SEC ↗ |
| 27 | Fidelity (FMR) ✦ | 16.38K | — | $238,449 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Millennium Management | $7.89M | 0.0% |
| AQR Capital Management | $807,105 | 0.0% |
| AQR Capital Management | $807,105 | 0.0% |
| AQR Capital Management | $807,105 | 0.0% |
| AQR Capital Management | $807,105 | 0.0% |
| AQR Capital Management | $807,105 | 0.0% |
| Renaissance Technologies | $240,240 | 0.0% |
Posición cerrada
| Point72 Asset Management | $4.46M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 129 tenedores, 49.02M acciones, $491.50M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.